静脈内免疫グロブリン(IVIg)の世界市場2020-2026:IVIg液体、IVIg粉末

QYResearchが発行した調査報告書(QYR20AP01173)
◆英語タイトル:Global Intravenous Immunoglobulin (IVIg) Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP01173
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月
◆ページ数:116
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥558,600見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥837,900見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,117,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、静脈内免疫グロブリン(IVIg)の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、静脈内免疫グロブリン(IVIg)のグローバル市場動向、メーカー別競争状況、種類別市場規模(IVIg液体、IVIg粉末)、用途別市場規模(免疫不全、自己免疫疾患、急性感染症)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・静脈内免疫グロブリン(IVIg)の種類別市場2015-2026:IVIg液体、IVIg粉末
・静脈内免疫グロブリン(IVIg)の用途別市場2015-2026:免疫不全、自己免疫疾患、急性感染症
・静脈内免疫グロブリン(IVIg)の北米市場分析
・静脈内免疫グロブリン(IVIg)のアジア市場分析
・静脈内免疫グロブリン(IVIg)の中南米市場分析
・静脈内免疫グロブリン(IVIg)の中東・アフリカ市場分析
・関連企業情報:Baxter、Grifols、CSL、Octapharma、Biotest、Kedrion、Hualan Bio、CNBG、Shanghai RAAS、CBPO、LFB Group、BPL、Sichuan Yuanda Shuyang
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.North America region is the largest supplier of intravenous immunoglobulin (IVIg), with a production market share nearly 48% in 2016. Europe is the second largest supplier of intravenous immunoglobulin (IVIg), enjoying production market share nearly 23% in 2016.
North America is the largest sales place, with a sales market share nearly 44% in 2016. Following North America, Europe is the second largest sales place with the sales market share of 22%.
Market competition is intense. Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
In 2019, the global Intravenous Immunoglobulin (IVIg) market size was US$ 9152.2 million and is forecast to US$ 13730 million in 2026, growing at a CAGR of 5.9% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Intravenous Immunoglobulin (IVIg).
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Intravenous Immunoglobulin (IVIg) market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Intravenous Immunoglobulin (IVIg) market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Intravenous Immunoglobulin (IVIg) market. Readers of the report can become informed about current and future trends of the global Intravenous Immunoglobulin (IVIg) market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Intravenous Immunoglobulin (IVIg) markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Intravenous Immunoglobulin (IVIg) market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Intravenous Immunoglobulin (IVIg) market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Intravenous Immunoglobulin (IVIg) market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Intravenous Immunoglobulin (IVIg) market is segmented into
IVIg Liquid
IVIg Powder

Market Segment by Application, the Intravenous Immunoglobulin (IVIg) market is segmented into
Immunodeficiency
Autoimmune Disease
Acute Infection

This report includes the following manufacturers; we can also add the other companies as you want.
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang

The study objectives are:
To analyze and research the global Intravenous Immunoglobulin (IVIg) status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Intravenous Immunoglobulin (IVIg) manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Intravenous Immunoglobulin (IVIg) are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Intravenous Immunoglobulin (IVIg) Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Intravenous Immunoglobulin (IVIg) Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 IVIg Liquid
1.3.3 IVIg Powder
1.4 Market Segment by Application
1.4.1 Global Intravenous Immunoglobulin (IVIg) Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Immunodeficiency
1.4.3 Autoimmune Disease
1.4.4 Acute Infection
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Intravenous Immunoglobulin (IVIg) Revenue (2015-2026)
2.1.1 Global Intravenous Immunoglobulin (IVIg) Revenue (2015-2026)
2.1.2 Global Intravenous Immunoglobulin (IVIg) Sales (2015-2026)
2.2 Intravenous Immunoglobulin (IVIg) Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Intravenous Immunoglobulin (IVIg) Sales by Regions (2015-2020)
2.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Regions (2015-2020)
2.3 Global Top Intravenous Immunoglobulin (IVIg) Regions (Countries) Ranking by Market Size
2.4 Intravenous Immunoglobulin (IVIg) Industry Trends
2.4.1 Intravenous Immunoglobulin (IVIg) Market Top Trends
2.4.2 Market Drivers
2.4.3 Intravenous Immunoglobulin (IVIg) Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Intravenous Immunoglobulin (IVIg) Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Intravenous Immunoglobulin (IVIg) Manufacturers by Sales (2015-2020)
3.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2015-2020)
3.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Intravenous Immunoglobulin (IVIg) Sales in 2019
3.2 Global Top Manufacturers Intravenous Immunoglobulin (IVIg) by Revenue
3.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2015-2020)
3.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Intravenous Immunoglobulin (IVIg) Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Immunoglobulin (IVIg) as of 2019)
3.4 Global Intravenous Immunoglobulin (IVIg) Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Intravenous Immunoglobulin (IVIg) Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Intravenous Immunoglobulin (IVIg) Market
3.7 Key Manufacturers Intravenous Immunoglobulin (IVIg) Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Intravenous Immunoglobulin (IVIg) Historic Market Review by Type (2015-2020)
4.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2015-2020)
4.1.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2015-2020)
4.1.4 Intravenous Immunoglobulin (IVIg) Price by Type (2015-2020)
4.1 Global Intravenous Immunoglobulin (IVIg) Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2021-2026)
4.2.3 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Type (2021-2026)
4.2.4 Intravenous Immunoglobulin (IVIg) Price Forecast by Type (2021-2026)

5 Global Intravenous Immunoglobulin (IVIg) Market Size by Application
5.1 Global Intravenous Immunoglobulin (IVIg) Historic Market Review by Application (2015-2020)
5.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2015-2020)
5.1.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2015-2020)
5.1.4 Intravenous Immunoglobulin (IVIg) Price by Application (2015-2020)
5.2 Global Intravenous Immunoglobulin (IVIg) Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2021-2026)
5.2.3 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Application (2021-2026)
5.2.4 Intravenous Immunoglobulin (IVIg) Price Forecast by Application (2021-2026)

6 North America
6.1 North America Intravenous Immunoglobulin (IVIg) Breakdown Data by Company
6.2 North America Intravenous Immunoglobulin (IVIg) Breakdown Data by Type
6.3 North America Intravenous Immunoglobulin (IVIg) Breakdown Data by Application
6.4 North America Intravenous Immunoglobulin (IVIg) Breakdown Data by Countries
6.4.1 North America Intravenous Immunoglobulin (IVIg) Sales by Countries
6.4.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Intravenous Immunoglobulin (IVIg) Breakdown Data by Company
7.2 Europe Intravenous Immunoglobulin (IVIg) Breakdown Data by Type
7.3 Europe Intravenous Immunoglobulin (IVIg) Breakdown Data by Application
7.4 Europe Intravenous Immunoglobulin (IVIg) Breakdown Data by Countries
7.4.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Countries
7.4.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Breakdown Data by Company
8.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Breakdown Data by Type
8.3 Asia Pacific Intravenous Immunoglobulin (IVIg) Breakdown Data by Application
8.4 Asia Pacific Intravenous Immunoglobulin (IVIg) Breakdown Data by Regions
8.4.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Regions
8.4.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Intravenous Immunoglobulin (IVIg) Breakdown Data by Company
9.2 Latin America Intravenous Immunoglobulin (IVIg) Breakdown Data by Type
9.3 Latin America Intravenous Immunoglobulin (IVIg) Breakdown Data by Application
9.4 Latin America Intravenous Immunoglobulin (IVIg) Breakdown Data by Countries
9.4.1 Latin America Intravenous Immunoglobulin (IVIg) Sales by Countries
9.4.2 Latin America Intravenous Immunoglobulin (IVIg) Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Breakdown Data by Type
10.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Breakdown Data by Application
10.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) Breakdown Data by Countries
10.3.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Countries
10.3.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Baxter Intravenous Immunoglobulin (IVIg) Products and Services
11.1.5 Baxter SWOT Analysis
11.1.6 Baxter Recent Developments
11.2 Grifols
11.2.1 Grifols Corporation Information
11.2.2 Grifols Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Grifols Intravenous Immunoglobulin (IVIg) Products and Services
11.2.5 Grifols SWOT Analysis
11.2.6 Grifols Recent Developments
11.3 CSL
11.3.1 CSL Corporation Information
11.3.2 CSL Business Overview and Total Revenue (2019 VS 2018)
11.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 CSL Intravenous Immunoglobulin (IVIg) Products and Services
11.3.5 CSL SWOT Analysis
11.3.6 CSL Recent Developments
11.4 Octapharma
11.4.1 Octapharma Corporation Information
11.4.2 Octapharma Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Products and Services
11.4.5 Octapharma SWOT Analysis
11.4.6 Octapharma Recent Developments
11.5 Biotest
11.5.1 Biotest Corporation Information
11.5.2 Biotest Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Biotest Intravenous Immunoglobulin (IVIg) Products and Services
11.5.5 Biotest SWOT Analysis
11.5.6 Biotest Recent Developments
11.6 Kedrion
11.6.1 Kedrion Corporation Information
11.6.2 Kedrion Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Products and Services
11.6.5 Kedrion SWOT Analysis
11.6.6 Kedrion Recent Developments
11.7 Hualan Bio
11.7.1 Hualan Bio Corporation Information
11.7.2 Hualan Bio Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Products and Services
11.7.5 Hualan Bio SWOT Analysis
11.7.6 Hualan Bio Recent Developments
11.8 CNBG
11.8.1 CNBG Corporation Information
11.8.2 CNBG Business Overview and Total Revenue (2019 VS 2018)
11.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 CNBG Intravenous Immunoglobulin (IVIg) Products and Services
11.8.5 CNBG SWOT Analysis
11.8.6 CNBG Recent Developments
11.9 Shanghai RAAS
11.9.1 Shanghai RAAS Corporation Information
11.9.2 Shanghai RAAS Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Products and Services
11.9.5 Shanghai RAAS SWOT Analysis
11.9.6 Shanghai RAAS Recent Developments
11.10 CBPO
11.10.1 CBPO Corporation Information
11.10.2 CBPO Business Overview and Total Revenue (2019 VS 2018)
11.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 CBPO Intravenous Immunoglobulin (IVIg) Products and Services
11.10.5 CBPO SWOT Analysis
11.10.6 CBPO Recent Developments
11.11 LFB Group
11.11.1 LFB Group Corporation Information
11.11.2 LFB Group Business Overview and Total Revenue (2019 VS 2018)
11.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Products and Services
11.11.5 LFB Group SWOT Analysis
11.11.6 LFB Group Recent Developments
11.12 BPL
11.12.1 BPL Corporation Information
11.12.2 BPL Business Overview and Total Revenue (2019 VS 2018)
11.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.12.4 BPL Intravenous Immunoglobulin (IVIg) Products and Services
11.12.5 BPL SWOT Analysis
11.12.6 BPL Recent Developments
11.13 Sichuan Yuanda Shuyang
11.13.1 Sichuan Yuanda Shuyang Corporation Information
11.13.2 Sichuan Yuanda Shuyang Business Overview and Total Revenue (2019 VS 2018)
11.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Products and Services
11.13.5 Sichuan Yuanda Shuyang SWOT Analysis
11.13.6 Sichuan Yuanda Shuyang Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Intravenous Immunoglobulin (IVIg) Sales Channels
12.2.2 Intravenous Immunoglobulin (IVIg) Distributors
12.3 Intravenous Immunoglobulin (IVIg) Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast (2021-2026)
13.1.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Regions (2021-2026)
13.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Intravenous Immunoglobulin (IVIg) Sales Forecast (2021-2026)
13.2.2 North America Intravenous Immunoglobulin (IVIg) Revenue Forecast (2021-2026)
13.2.3 North America Intravenous Immunoglobulin (IVIg) Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Intravenous Immunoglobulin (IVIg) Sales Forecast (2021-2026)
13.3.2 Europe Intravenous Immunoglobulin (IVIg) Revenue Forecast (2021-2026)
13.3.3 Europe Intravenous Immunoglobulin (IVIg) Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Forecast (2021-2026)
13.4.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Intravenous Immunoglobulin (IVIg) Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Intravenous Immunoglobulin (IVIg) Sales Forecast (2021-2026)
13.5.2 Latin America Intravenous Immunoglobulin (IVIg) Revenue Forecast (2021-2026)
13.5.3 Latin America Intravenous Immunoglobulin (IVIg) Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Intravenous Immunoglobulin (IVIg) Key Market Segments
Table 2. Ranking of Global Top Intravenous Immunoglobulin (IVIg) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Type 2021-2026 (K Bottle) & (Million US$)
Table 4. Major Manufacturers of IVIg Liquid
Table 5. Major Manufacturers of IVIg Powder
Table 6. Global Intravenous Immunoglobulin (IVIg) Market Share by Application 2019-2025 (K Bottle)
Table 7. Global Intravenous Immunoglobulin (IVIg) Market Size by Regions 2015-2020 (K Bottle) & (Million US$)
Table 8. Global Intravenous Immunoglobulin (IVIg) Sales by Regions 2015-2020 (K Bottle)
Table 9. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Regions 2015-2020
Table 10. Global Intravenous Immunoglobulin (IVIg) Revenue by Regions 2015-2020 (Million US$)
Table 11. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Regions 2015-2020
Table 12. Top Intravenous Immunoglobulin (IVIg) Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 13. Market Top Trends
Table 14. Intravenous Immunoglobulin (IVIg) Key Drivers: Impact Analysis (2021-2026)
Table 15. Intravenous Immunoglobulin (IVIg) Key Challenges
Table 16. Main Points Interviewed from Key Intravenous Immunoglobulin (IVIg) Players: Views for Future
Table 17. Global Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2015-2020) (K Bottle)
Table 18. Global Intravenous Immunoglobulin (IVIg) Sales Share by Manufacturers (2015-2020)
Table 19. Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2015-2020) (Million US$)
Table 20. Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers (2015-2020)
Table 21. Global Intravenous Immunoglobulin (IVIg) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Immunoglobulin (IVIg) as of 2019)
Table 23. Key Manufacturers Intravenous Immunoglobulin (IVIg) Average Selling Price (ASP) (2015-2020) (USD/Bottle)
Table 24. Key Manufacturers Intravenous Immunoglobulin (IVIg) Plants/Factories Distribution
Table 25. Key Manufacturers Intravenous Immunoglobulin (IVIg) Area Served
Table 26. Date of Key Manufacturers Enter into Intravenous Immunoglobulin (IVIg) Market
Table 27. Key Manufacturers Intravenous Immunoglobulin (IVIg) Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global IVIg Liquid Sales and Revenue (2015-2020) (K Bottle) & (Million US$)
Table 30. Global IVIg Powder Sales and Revenue (2015-2020) (K Bottle) & (Million US$)
Table 31. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Type (2015-2020)
Table 32. Global Intravenous Immunoglobulin (IVIg) Sales Share by Type (2015-2020)
Table 33. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 34. Global Intravenous Immunoglobulin (IVIg) Price (K Bottle) by Type (2015-2020)
Table 35. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Type (2021-2026)
Table 36. Global Intravenous Immunoglobulin (IVIg) Sales Share by Type (2021-2026)
Table 37. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 38. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2021-2026)
Table 39. Global Intravenous Immunoglobulin (IVIg) Price (K Bottle) by Type (2021-2026)
Table 40. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Application (2015-2020)
Table 41. Global Intravenous Immunoglobulin (IVIg) Sales Share by Application (2015-2020)
Table 42. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 43. Global Intravenous Immunoglobulin (IVIg) Price by Application 2015-2020 (USD/Bottle)
Table 44. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2015-2020) (K Bottle)
Table 45. Global Intravenous Immunoglobulin (IVIg) Sales Share by Application (2015-2020)
Table 46. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 47. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2021-2026)
Table 48. Global Intravenous Immunoglobulin (IVIg) Price (K Bottle) by Application (2021-2026)
Table 49. North America Intravenous Immunoglobulin (IVIg) Sales by Company (2015-2020) (K Bottle)
Table 50. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2015-2020)
Table 51. North America Intravenous Immunoglobulin (IVIg) Sales by Type (2015-2020) (K Bottle)
Table 52. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2015-2020)
Table 53. North America Intravenous Immunoglobulin (IVIg) Sales by Application (2015-2020) (K Bottle)
Table 54. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2015-2020)
Table 55. North America Intravenous Immunoglobulin (IVIg) Sales by Countries (2015-2020) (K Bottle)
Table 56. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries (2015-2020)
Table 57. North America Intravenous Immunoglobulin (IVIg) Revenue by Countries (2015-2020) (Million US$)
Table 58. North America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries (2015-2020)
Table 59. Europe Intravenous Immunoglobulin (IVIg) Sales by Company (2015-2020) (K Bottle)
Table 60. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2015-2020)
Table 61. Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2015-2020) (K Bottle)
Table 62. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2015-2020)
Table 63. Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2015-2020) (K Bottle)
Table 64. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2015-2020)
Table 65. Europe Intravenous Immunoglobulin (IVIg) Sales by Countries (2015-2020) (K Bottle)
Table 66. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries (2015-2020)
Table 67. Europe Intravenous Immunoglobulin (IVIg) Revenue by Countries (2015-2020) (Million US$)
Table 68. Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries (2015-2020)
Table 69. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Regions (2015-2020) (K Bottle)
Table 70. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Regions (2015-2020)
Table 71. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Type (2015-2020) (K Bottle)
Table 72. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2015-2020)
Table 73. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Application (2015-2020) (K Bottle)
Table 74. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2015-2020)
Table 75. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Countries (2015-2020) (K Bottle)
Table 76. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Regions (2015-2020)
Table 77. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Regions (2015-2020) (Million US$)
Table 78. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue Market Share by Regions (2015-2020)
Table 79. Latin America Intravenous Immunoglobulin (IVIg) Sales by Company (2015-2020) (K Bottle)
Table 80. Latin America Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2015-2020)
Table 81. Latin America Intravenous Immunoglobulin (IVIg) Sales by Type (2015-2020) (K Bottle)
Table 82. Latin America Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2015-2020)
Table 83. Latin America Intravenous Immunoglobulin (IVIg) Sales by Application (2015-2020) (K Bottle)
Table 84. Latin America Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2015-2020)
Table 85. Latin America Intravenous Immunoglobulin (IVIg) Sales by Countries (2015-2020) (K Bottle)
Table 86. Latin America Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries (2015-2020)
Table 87. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Countries (2015-2020) (Million US$)
Table 88. Latin America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries (2015-2020)
Table 89. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Type (2015-2020) (K Bottle)
Table 90. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2015-2020)
Table 91. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Application (2015-2020) (K Bottle)
Table 92. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2015-2020)
Table 93. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Countries (2015-2020) (K Bottle)
Table 94. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries (2015-2020)
Table 95. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Countries (2015-2020) (Million US$)
Table 96. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries (2015-2020)
Table 97. Baxter Company Details
Table 98. Baxter Description and Business Overview
Table 99. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 100. Baxter Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020)
Table 101. Baxter Intravenous Immunoglobulin (IVIg) Sales Market Share in Global Market
Table 102. Baxter Recent Development
Table 103. Grifols Company Details
Table 104. Grifols Description and Business Overview
Table 105. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 106. Grifols Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020)
Table 107. Grifols Intravenous Immunoglobulin (IVIg) Sales Market Share in Global Market
Table 108. Grifols Recent Development
Table 109. CSL Company Details
Table 110. CSL Description and Business Overview
Table 111. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 112. CSL Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020)
Table 113. CSL Intravenous Immunoglobulin (IVIg) Sales Market Share in Global Market
Table 114. CSL Recent Development
Table 115. Octapharma Company Details
Table 116. Octapharma Description and Business Overview
Table 117. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 118. Octapharma Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020)
Table 119. Octapharma Intravenous Immunoglobulin (IVIg) Sales Market Share in Global Market
Table 120. Octapharma Recent Development
Table 121. Biotest Company Details
Table 122. Biotest Description and Business Overview
Table 123. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 124. Biotest Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020)
Table 125. Biotest Intravenous Immunoglobulin (IVIg) Sales Market Share in Global Market
Table 126. Biotest Recent Development
Table 127. Kedrion Company Details
Table 128. Kedrion Description and Business Overview
Table 129. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 130. Kedrion Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020)
Table 131. Kedrion Intravenous Immunoglobulin (IVIg) Sales Market Share in Global Market
Table 132. Kedrion Recent Development
Table 133. Hualan Bio Company Details
Table 134. Hualan Bio Description and Business Overview
Table 135. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 136. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020)
Table 137. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales Market Share in Global Market
Table 138. Hualan Bio Recent Development
Table 139. CNBG Company Details
Table 140. CNBG Description and Business Overview
Table 141. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 142. CNBG Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020)
Table 143. CNBG Intravenous Immunoglobulin (IVIg) Sales Market Share in Global Market
Table 144. CNBG Recent Development
Table 145. Shanghai RAAS Company Details
Table 146. Shanghai RAAS Description and Business Overview
Table 147. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 148. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020)
Table 149. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales Market Share in Global Market
Table 150. Shanghai RAAS Recent Development
Table 151. CBPO Company Details
Table 152. CBPO Description and Business Overview
Table 153. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 154. CBPO Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020)
Table 155. CBPO Intravenous Immunoglobulin (IVIg) Sales Market Share in Global Market
Table 156. CBPO Recent Development
Table 157. LFB Group Company Details
Table 158. LFB Group Description and Business Overview
Table 159. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 160. LFB Group Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020)
Table 161. LFB Group Intravenous Immunoglobulin (IVIg) Sales Market Share in Global Market
Table 162. LFB Group Recent Development
Table 163. BPL Company Details
Table 164. BPL Description and Business Overview
Table 165. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 166. BPL Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020)
Table 167. BPL Intravenous Immunoglobulin (IVIg) Sales Market Share in Global Market
Table 168. BPL Recent Development
Table 169. Sichuan Yuanda Shuyang Company Details
Table 170. Sichuan Yuanda Shuyang Description and Business Overview
Table 171. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 172. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020)
Table 173. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales Market Share in Global Market
Table 174. Sichuan Yuanda Shuyang Recent Development
Table 175. Intravenous Immunoglobulin (IVIg) Distributors List
Table 176. Intravenous Immunoglobulin (IVIg) Customers List
Table 177. Global Intravenous Immunoglobulin (IVIg) Sales Forecast 2021-2026 (K Bottle) & (Million US$)
Table 178. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Type 2021-2026 (K Bottle)
Table 179. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Application 2021-2026 (K Bottle)
Table 180. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Regions 2021-2026 (K Bottle)
Table 181. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Regions 2021-2026 (Million US$)
Table 182. North America Intravenous Immunoglobulin (IVIg) Sales Forecast by Countries 2021-2026 (K Bottle)
Table 183. North America Intravenous Immunoglobulin (IVIg) Revenue Forecast by Countries 2021-2026
Table 184. Europe Intravenous Immunoglobulin (IVIg) Sales Forecast by Countries 2021-2026 (K Bottle)
Table 185. Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Countries 2021-2026
Table 186. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Forecast by Regions 2021-2026 (K Bottle)
Table 187. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue Forecast by Regions 2021-2026 (Million US$)
Table 188. Latin America Intravenous Immunoglobulin (IVIg) Sales Forecast by Countries 2021-2026 (K Bottle)
Table 189. Latin America Intravenous Immunoglobulin (IVIg) Revenue Forecast by Countries 2021-2026 (Million US$)
Table 190. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Forecast by Regions 2021-2026 (K Bottle)
Table 191. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Forecast by Regions 2021-2026 (Million US$)
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravenous Immunoglobulin (IVIg) Product Picture
Figure 2. Global Intravenous Immunoglobulin (IVIg) Sales Market Shar by Type 2015-2026
Figure 3. IVIg Liquid Figures
Figure 4. IVIg Powder Figures
Figure 5. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2019 & 2026
Figure 6. Immunodeficiency Use Case
Figure 7. Autoimmune Disease Use Case
Figure 8. Acute Infection Use Case
Figure 9. Intravenous Immunoglobulin (IVIg) Report Years Considered
Figure 10. Global Intravenous Immunoglobulin (IVIg) Market Size 2015-2026 (Million US$)
Figure 11. Global Intravenous Immunoglobulin (IVIg) Sales 2015-2020 (K Bottle)
Figure 12. Global Intravenous Immunoglobulin (IVIg) Market Size Market Share by Regions 2015-2020
Figure 13. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Regions in 2019
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Intravenous Immunoglobulin (IVIg) Sales Share by Manufacturers in 2019
Figure 16. The 5 and 10 Largest Manufacturers in the World: Market Share by Intravenous Immunoglobulin (IVIg) Sales in 2019
Figure 17. Intravenous Immunoglobulin (IVIg) Value Share by Manufacturers in 2019
Figure 18. Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers In 2019
Figure 19. Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2015-2020)
Figure 21. Global Intravenous Immunoglobulin (IVIg) Revenue Growth Rate by Type in 2015 & 2019
Figure 22. Global Intravenous Immunoglobulin (IVIg) Market Share by Price Range (2015-2020)
Figure 23. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2015-2020)
Figure 24. Global Intravenous Immunoglobulin (IVIg) Revenue Growth Rate by Application in 2015 & 2019
Figure 25. North America Intravenous Immunoglobulin (IVIg) Revenue Growth Rate 2015-2020 (Million US$)
Figure 26. U.S. Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 27. Canada Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 28. Europe Intravenous Immunoglobulin (IVIg) Revenue Growth Rate 2015-2020 (Million US$)
Figure 29. Germany Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 30. France Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 31. U.K. Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 32. Italy Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 33. Russia Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 34. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue Growth Rate 2015-2020 (Million US$)
Figure 35. China Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 36. Japan Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 37. South Korea Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 38. India Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 39. Australia Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 40. Taiwan Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 41. Indonesia Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 42. Thailand Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 43. Malaysia Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 44. Philippines Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 45. Vietnam Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 46. Latin America Intravenous Immunoglobulin (IVIg) Revenue Growth Rate 2015-2020 (Million US$)
Figure 47. Mexico Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 48. Brazil Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 49. Argentina Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 50. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Growth Rate 2015-2020 (Million US$)
Figure 51. Turkey Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 52. Saudi Arabia Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 53. U.A.E Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 54. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Grifols Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Octapharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Biotest Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Kedrion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Hualan Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. CNBG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Shanghai RAAS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. CBPO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. LFB Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. BPL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Sichuan Yuanda Shuyang Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Intravenous Immunoglobulin (IVIg) Value Chain
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 70. North America Intravenous Immunoglobulin (IVIg) Sales Growth Rate Forecast (2021-2026) (K Bottle)
Figure 71. North America Intravenous Immunoglobulin (IVIg) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 72. Europe Intravenous Immunoglobulin (IVIg) Sales Growth Rate Forecast (2021-2026) (K Bottle)
Figure 73. Europe Intravenous Immunoglobulin (IVIg) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 74. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Growth Rate Forecast (2021-2026) (K Bottle)
Figure 75. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 76. Latin America Intravenous Immunoglobulin (IVIg) Sales Growth Rate Forecast (2021-2026) (K Bottle)
Figure 77. Latin America Intravenous Immunoglobulin (IVIg) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 78. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Growth Rate Forecast (2021-2026) (K Bottle)
Figure 79. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed


【掲載企業】

Baxter、Grifols、CSL、Octapharma、Biotest、Kedrion、Hualan Bio、CNBG、Shanghai RAAS、CBPO、LFB Group、BPL、Sichuan Yuanda Shuyang

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 静脈内免疫グロブリン(IVIg)の世界市場2020-2026:IVIg液体、IVIg粉末(Global Intravenous Immunoglobulin (IVIg) Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。